












傷直後から COA-Cl を５日間腹腔内投与した COA-Cl 群と，同量の生理食塩水を投与した vehicle
群に分けた．脊髄損傷14日後に運動機能を Basso-Beattie-Bresnahan Locomotor Rating Scale ス
コア（BBB スコア）と傾斜台試験にて，血管新生をラミニンの免疫染色により後索の血管数と
血管面積を測定することで評価した．運動機能は BBB スコアと傾斜台試験ともに COA-Cl 群で





















































































































































































































あり，頭側5.0 mm（p = 0.008），尾側2.5 mm（p 






図２　脊髄損傷 14 日後の血管数および血管面積 抗ラミニン抗体を用いた組織
免疫染色像よりカウントした．
ａ）COA-Cl群，ｂ）Vehicle群の後索領域のラミニン染色像 スケール =50 µm，
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The angiogenesis and functional recovery effect after spinal cord  
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ABSTRACT   2-chloro-carbocyclic oxetanocin A (COA-Cl), a novel synthesized adenosine 
analog, has been reported to have a strong angiogenic effect. In our previous study using a rat 
model of stroke, we showed the neuroprotective, angiogenic and motor recovery effects of COA-
Cl. Spinal cord injury (SCI) induces severe motor dysfunction and lowers the quality of life. In 
our recent study, we demonstrated that acute-phase administration of COA-Cl protects against 
spinal cord damage and facilitates motor recovery after SCI. In this study, we hypothesized 
that acute-phase administration of COA-Cl post-SCI also induces early neovascularization 
and participates in motor function recovery. SCI was induced using a drop device in rats. Rats 
with SCI were divided into 2 groups: COA-Cl and vehicle groups (n = 5 in each group). COA-
Cl was intraperitoneally injected (6 mg/kg in saline) once a day for 5 days immediately after 
SCI. In the vehicle group, only saline was administered, with the same dosing regimen as that 
in the COA-Cl group. Fourteen days after SCI, motor function was evaluated based on Basso–
Beattie–Bresnahan scoring and the inclined plane test. To evaluate angiogenesis, cryosections 
of the spinal cord were immunostained with anti-laminin antibody. Motor function significantly 
improved in the COA-Cl group compared with that in the vehicle group; concomitantly, both 
the number and volume of blood vessels significantly increased in the COA-Cl group compared 
with those in the vehicle group. In conclusion, acute-phase administration of COA-Cl results in 
motor function recovery, which may be attributed to angiogenic effects.
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